cgp 42112a has been researched along with angiotensin ii, des-phe(8)- in 12 studies
Studies (cgp 42112a) | Trials (cgp 42112a) | Recent Studies (post-2010) (cgp 42112a) | Studies (angiotensin ii, des-phe(8)-) | Trials (angiotensin ii, des-phe(8)-) | Recent Studies (post-2010) (angiotensin ii, des-phe(8)-) |
---|---|---|---|---|---|
233 | 0 | 35 | 1,533 | 21 | 995 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (50.00) | 18.2507 |
2000's | 2 (16.67) | 29.6817 |
2010's | 4 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aguilar, MI; Bosnyak, S; Christopoulos, A; Jones, ES; Thomas, WG; Widdop, RE | 1 |
Diz, DI; Ferrario, CM; Jaiswal, N; Khosla, MC; Tallant, EA | 1 |
Barnes, KL; Felix, D; Ferrario, CM; Imboden, H; Khosla, MC; Montani, B | 1 |
Smith, RD | 1 |
Campagnole-Santos, MJ; Fontes, MA; Guertzenstein, PG; Khosla, MC; Santos, RA; Silva, LC | 1 |
Cooney, AS; Fitzsimons, JT | 1 |
Campagnole-Santos, MJ; Fontes, MA; Khosla, MC; Lopes, OU; Martins Pinge, MC; Naves, V; Santos, RA | 1 |
Alenina, N; Bader, M; Lemos, VS; Santos, RA; Silva, DM; Walther, T | 1 |
Kautiainen, H; Oksala, O; Vaajanen, A; Vapaatalo, H | 1 |
Ager, EI; Chan, J; Chong, WW; Christophi, C; Neo, JH; Wen, SW | 1 |
Durand, MJ; Lombard, JH; Raffai, G | 1 |
Ali, Q; Hussain, T; Wu, Y | 1 |
12 other study(ies) available for cgp 42112a and angiotensin ii, des-phe(8)-
Article | Year |
---|---|
Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors.
Topics: Angiotensins; Drug Design; Drug Evaluation, Preclinical; HEK293 Cells; Humans; Imidazoles; Inhibitory Concentration 50; Ligands; Peptides; Plasmids; Proto-Oncogene Mas; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Transfection | 2011 |
Characterization of angiotensin receptors mediating prostaglandin synthesis in C6 glioma cells.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Glioma; Imidazoles; Losartan; Oligopeptides; Peptide Fragments; Prostaglandins; Receptors, Angiotensin; Tetrazoles; Tumor Cells, Cultured | 1991 |
Neurophysiological responses to angiotensin-(1-7).
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Animals; Brain; Electrophysiology; Female; Iontophoresis; Neurons; Oligopeptides; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Rats; Rats, Inbred WKY; Vasopressins | 1991 |
Identification of atypical (non-AT1, non-AT2) angiotensin binding sites with high affinity for angiotensin I on IEC-18 rat intestinal epithelial cells.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Binding Sites; Binding, Competitive; Biphenyl Compounds; Cell Line; Epithelium; Imidazoles; Intestinal Mucosa; Intestine, Small; Losartan; Oligopeptides; Peptide Fragments; Pyridines; Rats; Receptors, Angiotensin; Tetrazoles | 1995 |
Evidence that angiotensin-(1-7) plays a role in the central control of blood pressure at the ventro-lateral medulla acting through specific receptors.
Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Imidazoles; Losartan; Male; Medulla Oblongata; Oligopeptides; Peptide Fragments; Rats; Rats, Wistar; Tetrazoles | 1994 |
The effect of the putative AT2 agonist, p-aminophenylalanine6 angiotensin II, on thirst and sodium appetite in rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Appetite; Biphenyl Compounds; Drinking; Imidazoles; Injections, Intraventricular; Losartan; Male; Oligopeptides; Peptide Fragments; Pyridines; Rats; Rats, Wistar; Receptors, Angiotensin; Sodium Chloride, Dietary; Tetrazoles; Thirst | 1993 |
Cardiovascular effects produced by microinjection of angiotensins and angiotensin antagonists into the ventrolateral medulla of freely moving rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Heart Rate; Imidazoles; Losartan; Male; Medulla Oblongata; Microinjections; Oligopeptides; Peptide Fragments; Rats; Rats, Wistar; Tetrazoles; Time Factors | 1997 |
The endothelium-dependent vasodilator effect of the nonpeptide Ang(1-7) mimic AVE 0991 is abolished in the aorta of mas-knockout mice.
Topics: Angiotensin I; Angiotensin II; Animals; Aorta, Thoracic; Endothelium, Vascular; Enzyme Inhibitors; Imidazoles; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Oligopeptides; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Vasoconstrictor Agents; Vasodilator Agents | 2005 |
Angiotensin (1-7) reduces intraocular pressure in the normotensive rabbit eye.
Topics: Administration, Topical; Angiotensin I; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Aqueous Humor; Dose-Response Relationship, Drug; Imidazoles; Injections; Intraocular Pressure; Male; Oligopeptides; Peptide Fragments; Pyridines; Rabbits; Receptor, Angiotensin, Type 2; Tonometry, Ocular; Vitreous Body | 2008 |
Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation.
Topics: Adenocarcinoma; Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers, Tumor; Biphenyl Compounds; Captopril; Colorectal Neoplasms; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Gene Expression Regulation, Neoplastic; Irbesartan; Liver Neoplasms, Experimental; Mice; Mice, Inbred CBA; Molecular Targeted Therapy; Neoplasm Proteins; Neovascularization, Pathologic; Oligopeptides; Peptide Fragments; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Tetrazoles; Tumor Burden; Up-Regulation; Vascular Endothelial Growth Factor A | 2011 |
Acute and chronic angiotensin-(1-7) restores vasodilation and reduces oxidative stress in mesenteric arteries of salt-fed rats.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Blotting, Western; Ethidium; Fluorescent Dyes; Male; Mesenteric Arteries; Nitric Oxide; Oligopeptides; Oxidative Stress; Peptide Fragments; Rats; Rats, Sprague-Dawley; Sodium, Dietary; Superoxide Dismutase; Superoxides; Up-Regulation; Vasodilation; Vasodilator Agents | 2011 |
Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Antihypertensive Agents; Blood Pressure; Cell Line; Disease Models, Animal; Glomerular Filtration Rate; Humans; Hypertension; Kidney Cortex; Male; Natriuresis; Obesity; Oligopeptides; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Zucker; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renin; Renin-Angiotensin System; Time Factors; Up-Regulation | 2013 |